🇺🇸 FDA
Company

Neumora

Neumora Therapeutics

NMRA biotech USA

Quick answer

Neumora is a biotech company (NMRA) headquartered in WATERTOWN, MA, USA with 3 tracked pipeline programs.

Pipeline (3)

project

NMRA-335140

Major Depressive Disorder

Phase 3 · small_molecule · active

5 trials project

NMRA-335140 80 mg

Major Depressive Episode Associated With Bipolar II Disorder

Phase 2 · small_molecule · completed

1 trials project

NMRA-323511

Alzheimer's Disease

Phase 1 · small_molecule · completed

1 trials

Patents (6)

patent

US 12371414

Methods of treating neurological disorders

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12247037

1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A]

Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12171758

Crystalline salt forms of kappa opioid receptor antagonist and products and meth

Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12152038

Vasopressin receptor antagonists and products and methods related thereto

Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11993580

Methods of treating neurological disorders

Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11858943

Vasopressin receptor antagonists and products and methods related thereto

Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)